Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction. Results of the CHARM low left ventricular ejection fraction trials. - Young,J.B.; Dunlap,M.E.; Pfeffer,M.A. (Circulation, 2004)